NEW PATIENTS: PLEASE CALL (833) CPS-0071 OPEN WEEKDAYS 8:00AM – 6:00PM PACIFIC TIME
YOU ARE NOT ALONE...
6M+
Adults in the US have Alzheimer’s...
4 in 10
Only
Americans talk to their doctor
What Causes Alzheimer’s Disease?
While the precise origins of Alzheimer's disease remain elusive, scientists recognize that it likely results from a complex interplay of factors.
Protein Accumulation
Alzheimer's is characterized by the abnormal buildup of proteins, particularly amyloid, forming plaques around brain cells.
Age-Related Changes
The aging process contributes to changes in the brain, playing a role in the development of Alzheimer's.
Neuronal Disruption
The accumulated proteins, especially amyloid, disrupt the normal functioning of neurons, leading to a cascade of detrimental events.
Genetic Factors
In less than 1% of cases, specific genetic changes significantly increase the risk, often leading to the onset of Alzheimer's in middle age.
Lifestyle Influence
Lifestyle choices and environmental factors are believed to interact with genetic predispositions, influencing the risk of Alzheimer's over time.
.png)
Treatment Options for Alzheimer's Disease
There's no cure for Alzheimer’s, but treatments aim to manage symptoms and potentially slow disease progression. Drug and non-drug options exist to enhance the quality of life for individuals with Alzheimer's and support caregivers:
-
Medications for Mild to Moderate Alzheimer’s Disease: Galantamine, rivastigmine, and donepezil can be prescribed to manage cognitive and behavioral symptoms in the early to moderate stages of Alzheimer’s. These drugs prevent the breakdown of acetylcholine, a brain chemical crucial for memory and thinking.
-
Immunotherapies: Lecanemab and aducanumab target beta-amyloid protein, reducing amyloid plaques in early Alzheimer’s. Insurance coverage may be limited, and thorough evaluation, including PET scans or cerebrospinal fluid analysis, is crucial due to potential serious side effects.
-
Medications for Moderate to Severe Alzheimer’s Disease:
-
Memantine (NMDA Antagonist): Regulates glutamate to delay symptom progression.
-
Combination Medications: Donepezil, rivastigmine patch, and a combination of the two are approved for moderate to severe Alzheimer’s.
-
Managing Behavioral Symptoms: Brexpiprazole: An atypical antipsychotic approved for treating agitation in Alzheimer’s patients. Caution is advised due to potential side effects.
Alzheimer’s Disease FAQs
WHY CPS
Comprehensive Psychiatric Services (CPS) stands as a forefront provider of compassionate assistance for individuals navigating Alzheimer's challenges. Our adept professionals specialize in addressing the complexities of Alzheimer's disease, delivering expert and personalized care. At CPS, we are committed to evidence-based treatments, thorough assessments, and a patient-centered approach, positioning us as a top choice for those seeking effective support in managing Alzheimer's.
PSYCHIATRISTS WHO CARE!
Reach out to use today
.png)